BIOA Earnings Bioage Labs, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–11 of 11
| Q1 2026 | 2026-03-31 | -0.52 | 2026-05-08 | 10-Q |
| FY 2025 | 2025-12-31 | -2.24 | 2026-03-24 | 10-K |
| Q3 2025 | 2025-09-30 | -1.52 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.96 | 2025-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.36 | 2026-05-08 | 10-Q |
| FY 2025 | 2024-12-31 | -6.63 | 2026-03-24 | 10-K |
| Q3 2025 | 2024-09-30 | -21.76 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -15.70 | 2025-08-06 | 10-Q |
| Q1 2025 | 2024-03-31 | -7.76 | 2025-05-06 | 10-Q |
| FY 2024 | 2023-12-31 | -38.17 | 2025-03-20 | 10-K |
| Q3 2024 | 2023-09-30 | -25.64 | 2024-11-07 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.